• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thrombotic microangiopathy: atypical HUS: current diagnostic and therapeutic approaches.

作者信息

Rosales Alejandra, Riedl Magdalena, Zimmerhackl Lothar B

出版信息

Nat Rev Nephrol. 2010 Sep;6(9):504-6. doi: 10.1038/nrneph.2010.98.

DOI:10.1038/nrneph.2010.98
PMID:20736981
Abstract
摘要

相似文献

1
Thrombotic microangiopathy: atypical HUS: current diagnostic and therapeutic approaches.血栓性微血管病：非典型溶血尿毒综合征：当前的诊断和治疗方法
Nat Rev Nephrol. 2010 Sep;6(9):504-6. doi: 10.1038/nrneph.2010.98.
2
Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).血栓性微血管病（TMAs）诊断与治疗的病理会诊
Am J Clin Pathol. 2016 Feb;145(2):158-65. doi: 10.1093/ajcp/aqv086.
3
Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.早期鉴别危重症成人血栓性微血管病综合征中与志贺毒素相关的溶血尿毒综合征。
Crit Care Med. 2018 Sep;46(9):e904-e911. doi: 10.1097/CCM.0000000000003292.
4
Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.血栓性微血管病：血浆置换的当前认知与治疗效果
Semin Dial. 2012 Mar-Apr;25(2):214-9. doi: 10.1111/j.1525-139X.2011.01035.x. Epub 2012 Feb 7.
5
[Hemolytic and uremic syndrome and related thrombotic microangiopathies: Treatment and prognosis].[溶血尿毒综合征及相关血栓性微血管病：治疗与预后]
Rev Med Interne. 2017 Dec;38(12):833-839. doi: 10.1016/j.revmed.2017.07.005. Epub 2017 Sep 22.
6
Thrombotic microangiopathies (TTP, HUS, HELLP).血栓性微血管病（血栓性血小板减少性紫癜、溶血尿毒综合征、伴有肝酶升高和血小板减少的子痫前期）
Emerg Med Clin North Am. 2014 Aug;32(3):649-71. doi: 10.1016/j.emc.2014.04.008. Epub 2014 Jun 3.
7
Haemolytic uremic syndrome: diagnosis and management.溶血性尿毒症综合征：诊断与管理
F1000Res. 2019 Sep 25;8. doi: 10.12688/f1000research.19957.1. eCollection 2019.
8
[Thrombotic microangiopathy: when time is the key factor!].[血栓性微血管病：时间为何是关键因素！]
Rev Med Suisse. 2014 Apr 9;10(425):794, 796-803.
9
Where are we with haemolytic uremic syndrome?我们在溶血尿毒综合征方面处于什么阶段？
Med Clin (Barc). 2018 Oct 23;151(8):329-335. doi: 10.1016/j.medcli.2018.02.016. Epub 2018 Apr 24.
10
Syndromes of Thrombotic Microangiopathy.血栓性微血管病综合征。
Med Clin North Am. 2017 Mar;101(2):395-415. doi: 10.1016/j.mcna.2016.09.010. Epub 2016 Dec 27.

引用本文的文献

1
Ulcerative Colitis Gone Rogue: A Case of Complement-Mediated Thrombotic Microangiopathy in Inflammatory Bowel Disease.溃疡性结肠炎失控：炎症性肠病中补体介导的血栓性微血管病一例
Cureus. 2025 Feb 3;17(2):e78447. doi: 10.7759/cureus.78447. eCollection 2025 Feb.
2
Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.关于非典型溶血性尿毒症综合征的诊断和治疗的共识。
Korean J Intern Med. 2020 Jan;35(1):25-40. doi: 10.3904/kjim.2019.388. Epub 2020 Jan 2.
3
Atypical hemolytic-uremic syndrome: a case report and literature review.

本文引用的文献

1
Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.非典型溶血性尿毒症综合征肾移植后的预防性依库珠单抗治疗
N Engl J Med. 2010 May 6;362(18):1746-8. doi: 10.1056/NEJMc1001060.
2
Atypical hemolytic-uremic syndrome.非典型溶血尿毒综合征
N Engl J Med. 2009 Oct 22;361(17):1676-87. doi: 10.1056/NEJMra0902814.
3
Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.英国不典型溶血尿毒综合征管理临床实践指南。
非典型溶血尿毒综合征：一例病例报告及文献综述
Am J Case Rep. 2015 Feb 24;16:109-14. doi: 10.12659/AJCR.892907.
4
Thrombotic microangiopathy and associated renal disorders.血栓性微血管病及相关肾脏疾病。
Nephrol Dial Transplant. 2012 Jul;27(7):2673-85. doi: 10.1093/ndt/gfs279.
5
Differentiating scleroderma renal crisis from other causes of thrombotic microangiopathy in a postpartum patient.产后患者中硬皮病肾危象与其他血栓性微血管病病因的鉴别。
Clin Nephrol. 2013 Oct;80(4):293-7. doi: 10.5414/CN107465.
6
Atypical hemolytic uremic syndrome.非典型溶血尿毒综合征。
Orphanet J Rare Dis. 2011 Sep 8;6:60. doi: 10.1186/1750-1172-6-60.
Br J Haematol. 2010 Jan;148(1):37-47. doi: 10.1111/j.1365-2141.2009.07916.x. Epub 2009 Oct 11.
4
The role of complement inhibition in PNH.补体抑制在阵发性睡眠性血红蛋白尿症中的作用。
Hematology Am Soc Hematol Educ Program. 2008:116-23. doi: 10.1182/asheducation-2008.1.116.
5
Complement and the atypical hemolytic uremic syndrome in children.补体与儿童非典型溶血尿毒综合征
Pediatr Nephrol. 2008 Nov;23(11):1957-72. doi: 10.1007/s00467-008-0872-4. Epub 2008 Jul 2.
6
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.膜辅因子蛋白（MCP；CD46）初始突变导致非典型溶血尿毒综合征的影响。
Mol Immunol. 2007 Jan;44(1-3):111-22. doi: 10.1016/j.molimm.2006.07.004. Epub 2006 Aug 1.
7
A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.溶血尿毒综合征、血栓性血小板减少性紫癜及相关疾病的分类
Kidney Int. 2006 Aug;70(3):423-31. doi: 10.1038/sj.ki.5001581. Epub 2006 Jun 14.
8
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.溶血尿毒综合征的遗传学：MCP、CFH和IF突变对临床表现、治疗反应及预后的影响
Blood. 2006 Aug 15;108(4):1267-79. doi: 10.1182/blood-2005-10-007252. Epub 2006 Apr 18.
9
Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome.复发性溶血尿毒综合征患儿的终末补体复合物（C5b-9）
Semin Thromb Hemost. 2006 Mar;32(2):121-7. doi: 10.1055/s-2006-939768.
10
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.血管性血友病因子裂解蛋白酶（ADAMTS13）在复发性和家族性血栓性血小板减少性紫癜及溶血性尿毒症综合征中缺乏。
Blood. 2002 Aug 1;100(3):778-85. doi: 10.1182/blood-2001-12-0166.